Bladder Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Bladder Cancer
Other PDQ summaries containing information related to bladder cancer include the following:
Bladder and Other Urothelial Cancers Screening
Unusual Cancers of Childhood (bladder cancer in children)
American Cancer Society.: Cancer Facts and Figures 2013. Atlanta, Ga: American Cancer Society, 2013. Available online. Last accessed March 13, 2013.
Hudson MA, Herr HW: Carcinoma in situ of the bladder. J Urol 153 (3 Pt 1): 564-72, 1995.
Torti FM, Lum BL: The biology and treatment of superficial bladder cancer. J Clin Oncol 2 (5): 505-31, 1984.
Lacombe L, Dalbagni G, Zhang ZF, et al.: Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome. J Clin Oncol 14 (10): 2646-52, 1996.
Stein JP, Grossfeld GD, Ginsberg DA, et al.: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 160 (3 Pt 1): 645-59, 1998.
Witjes JA, Caris CT, Mungan NA, et al.: Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. J Urol 160 (5): 1668-71; discussion 1671-2, 1998.
Quek ML, Stein JP, Nichols PW, et al.: Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 174 (1): 103-6, 2005.
Thrasher JB, Crawford ED: Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 149 (5): 957-72, 1993.
Esrig D, Elmajian D, Groshen S, et al.: Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331 (19): 1259-64, 1994.
Lipponen PK: Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 53 (3): 365-70, 1993.